Who makes Ritonavir and Pyramax?

Ritonavir and Pyramax is developed by Medicines for Malaria Venture.

What development phase is Ritonavir and Pyramax in?

Ritonavir and Pyramax is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Ritonavir and Pyramax

Medicines for Malaria Venture · Phase 1 active Small molecule

At a glance

Generic name	Ritonavir and Pyramax
Sponsor	Medicines for Malaria Venture
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pyronaridine Artesunate-Ritonavir Drug-drug Interaction Study (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Ritonavir and Pyramax CI brief — competitive landscape report
Ritonavir and Pyramax updates RSS · CI watch RSS
Medicines for Malaria Venture portfolio CI